| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 9e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |